CompletedPHASE2, PHASE3NCT00407082
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants
Studying Infectious posterior uveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bausch & Lomb Incorporated
- Principal Investigator
- Thomas A CrescuilloBausch & Lomb Incorporated
- Intervention
- fluocinolone acetonide intravitreal implant(drug)
- Enrollment
- 278 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2000 – 2005
Study locations (1)
- Duke Eye Center, Durham, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00407082 on ClinicalTrials.gov